Marsha Stabler Hardiman BS

Marsha Stabler Hardiman has over 28 years of experience in the pharmaceutical, biopharmaceutical, cell therapy/gene therapy and medical device industries with extensive experience in Quality and Microbiology. Marsha's leadership experience includes global experience with manufacturing locations in Noth and South America, Europe and Asia. Hardiman has strong quality auditing experience for requirements to FDA, EMEA, ISO and other national regulatory requirements. Marsha's experience includes being a notified body inspector for ISO/CE marking. Hardiman is actively involved in the Parenteral Drug Association (PDA). Hardiman is a member of the ATMP Advisory Board and a prior member of the Scientific Advisory Board (SAB), the Education Advisory Board (EAB), the Annual Microbiology Meeting planning committee as well as numerous task forces. Hardiman was Co-Chair of the 2011 Annual Meeting and Chair of the 2012 Annual Meeting. Hardiman routinely conducts training courses and webinars sharing Marsha's experiences with the industry.